Whitepapers
Explore our selection of downloadable whitepapers, offering insights into the latest advancements in drug testing technology. These documents are essential for healthcare professionals, compliance officers, and researchers, providing up-to-date trends, breakthroughs, and best practices in the field.
Explore Our Comprehensive Collection of White Papers: Your Gateway to the Latest Innovations in Drug Testing Technology
Psychemedics 2026 Workforce Insights Report
This whitepaper examines the rapidly evolving drug landscape facing today’s employers and makes the case for hair testing as the most reliable defense against rising workforce risk. Drawing on hair testing data from 2025, it reveals a workforce shaped by escalating drug potency, surging poly-substance use, and the rapid spread of “legal but impairing” substances like Kratom/7-OH and hemp-derived Delta-8 and Delta-10 THC, all complicated by expanding state legalization and pending federal cannabis rescheduling. With industry-by-industry positivity breakdowns showing healthcare at a five-year high of 20.2%, manufacturing holding at 12.4%, and transportation improving but still carrying meaningful risk, the report demonstrates why short-window urine and oral fluid tests routinely miss the lifestyle and chronic users who pose the greatest safety threat. Backed by a 90-day detection window, tamper resistance, and FDA-cleared methodology, hair testing gives employers the longitudinal visibility needed to align workplace policy with real-world impairment risk rather than legal labels alone.
Click the image to download the whitepaper.
The ROI of Advanced Drug Testing: Why Hair Testing Outperforms Traditional Methods
This whitepaper breaks down the real return on investment behind hair drug testing, showing why it outperforms urine and oral fluid methods in both detection power and cost efficiency. It explores how workplace substance abuse drives billions in lost productivity, higher accident rates, and increased turnover — and how hair testing’s 90-day detection window and tamper-proof methodology help employers identify chronic users that traditional tests routinely miss. With side-by-side cost-per-positive comparisons and real-world case studies showing dramatic reductions in drug-related incidents, this paper gives employers the data they need to make the case for smarter, more effective screening programs.
The Impact of Drug Use on Workplace Productivity and Safety: How Hair Testing Can Help Mitigate Risk
Drug News You Can Use
Sign up for our quarterly newsletter to stay up-to-date with snapshots of usage statistics, information on the latest trends, and updates on detection science.















